Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostatic Neoplasms, Prostatectomy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT01173146
What this trial is testing

Imaging of Residual Tumor During Prostatectomy

Who this might be right for
Prostate Cancer
Spectros Corporation
Not applicableLooking for participantsNCT07101731
What this trial is testing

Effects of Hypopressive Exercises on Urinary Incontinence and Erectile Dysfunction After Radical Prostatectomy

Who this might be right for
Prostate Cancer (Post Prostatectomy)Urinary IncontinenceErectile Dysfunction Following Radical Prostatectomy+1 more
Bartın Unıversity 30
Not applicableStudy completedNCT01086956
What this trial is testing

Effect of Adding Sufentanil to Epidural Ropivacaine on Perioperative Metabolic and Stress Responses in Combined General/Epidural Anaesthesia for Geriatric Radical Retropubic Prostatectomy

Who this might be right for
Prostatic Cancer
Yonsei University 60
Not applicableStudy completedNCT00235794
What this trial is testing

An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients

Who this might be right for
Prostatic Neoplasms
Wyeth is now a wholly owned subsidiary of Pfizer 50
Testing effectiveness (Phase 2)Study completedNCT00027794
What this trial is testing

Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 40
Testing effectiveness (Phase 2)Study completedNCT00241475
What this trial is testing

Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy

Who this might be right for
Prostate Cancer
AstraZeneca 30
Not applicableActive Not RecruitingNCT05027477
What this trial is testing

A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Profound Medical Inc. 201
Testing effectiveness (Phase 2)WithdrawnNCT02678520
What this trial is testing

Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients

Who this might be right for
Prostate Cancer
University of Kansas Medical Center
Large-scale testing (Phase 3)Study completedNCT02981368
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 385
Not applicableLooking for participantsNCT06318559
What this trial is testing

Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention

Who this might be right for
Cancer of Prostate
Fondazione del Piemonte per l'Oncologia 120
Testing effectiveness (Phase 2)Study completedNCT03362359
What this trial is testing

Ga-68-PSMA-11 in High-risk Prostate Cancer

Who this might be right for
High-risk Prostate CancerProstate CancerProstate Cancer Metastatic+1 more
German Cancer Research Center 173
Not applicableStudy completedNCT02151097
What this trial is testing

PRIME - PRostate Imaging for Margin Evaluation

Who this might be right for
Prostatic Neoplasms
Lightpoint Medical Limited 7
Post-approval studies (Phase 4)Ended earlyNCT01770340
What this trial is testing

Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial

Who this might be right for
Erectile Dysfunction Following Radical Prostatectomy
Kantonsspital Winterthur KSW 30
Large-scale testing (Phase 3)Active Not RecruitingNCT06235151
What this trial is testing

Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Curium US LLC 439
Testing effectiveness (Phase 2)Study completedNCT01751451
What this trial is testing

3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 124
Testing effectiveness (Phase 2)Study completedNCT01868386
What this trial is testing

Shorter Duration Radiotherapy to Treat Prostate Cancer After Removal of the Prostate

Who this might be right for
Prostate Cancer
Timothy Showalter, MD 32
Not applicableStudy completedNCT01325506
What this trial is testing

Effectiveness of Open and Robotic Prostatectomy

Who this might be right for
Prostate Cancer
Beth Israel Deaconess Medical Center 677
Testing effectiveness (Phase 2)Study completedNCT00223665
What this trial is testing

Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 102
Testing effectiveness (Phase 2)Study completedNCT00017563
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 57
Not applicableStudy completedNCT03091231
What this trial is testing

Multiparametric Ultrasound-Study for the Detection of Prostate Cancer

Who this might be right for
Prostate Cancer
Martini-Klinik am UKE GmbH 50
Next Page